Certara UK LIMITED
Acero, England Part of Certara USA Inc.
- UEI
- WWBMG5E7KT69
- CAGE
- U03U4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Radnor, PA
HWLYE4KDVHB6
-
Parent
Radnor, PA
HWLYE4KDVHB6
- SAM.gov registration date
- Physical address
- 1 Concourse Way, Sheffield City Centre, Acero, Sheffield S1 2BJ, UK
- Website
- certara.com
- Founded
- 2008
- Employees
- 1K-5K
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $523,910 |
| FY2025 | $162,802 |
| FY2024 | $167,439 |
| FY2023 | $159,353 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $523,910 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Northeastern University | U01FD007656 | $25,005 | |
| Northeastern University | U01FD007656 | $24,996 | |
| University Of Texas At Austin | U01FD008303 | $88,998 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Certara USA Inc. | Radnor, PA | 513210 Software Publishers |
| Simulations Plus Inc. | Durham, NC | 513210 Software Publishers |
| Icon Clinical Research LLC | Blue Bell, PA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Institute For Clinical Pharmacodynamics, Inc. | Schenectady, NY | 541690 Other Scientific and Technical Consulting Services |
| Lhasa LIMITED | England | 513210 Software Publishers |
About the company
Certara UK LIMITED, doing business as Certara, delivers physiologically-based pharmacokinetic (PBPK) modeling software, virtual bioequivalence platforms, and regulatory science research and development services to federal agencies as a prime contractor (90% of recent awards) and as a sub-recipient on FDA-funded grants. Certara UK is a for-profit limited liability company headquartered in Sheffield, United Kingdom, operating as a child entity under parent Certara USA Inc. (based in Radnor, Pennsylvania). The vendor competes on full-and-open solicitations with no set-aside designations across its federal footprint.
Certara's federal work concentrates heavily on software licensing and regulatory science modeling for drug development and approval workflows. The vendor's core capability centers on SIMCYP, a PBPK software platform used by the FDA's Office of Clinical Pharmacology to simulate drug absorption, distribution, metabolism, and excretion in virtual patient populations, supporting review of investigational new drugs, new drug applications, biologics license applications, and abbreviated new drug applications. Representative prime work includes a $1,083,957 definitive contract awarded by the FDA on September 30, 2026, under the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, focused on advancing integration of in vitro topical product characterization and skin permeation data (completion date September 29, 2029); a $815,948 FDA SIMCYP software license purchase order issued September 6, 2023, exercising option period 3 (completion date September 20, 2028); and a $114,316 FDA purchase order for SIMCYP licenses and maintenance support awarded September 9, 2022, to support the Office of Clinical Pharmacology's drug review workflow. Certara also holds two FDA cooperative agreements as prime recipient: a September 1, 2023 award (completion date August 31, 2027) for developing a formulation toolbox for topically applied drugs accounting for dynamic metamorphosis and excipient influence, and a July 3, 2023 cooperative agreement (completion date July 2, 2026) for developing a state-of-the-art virtual bioequivalence platform and case studies on complex formulations.
Customer concentration is narrow and agency-focused. The FDA accounts for 13 awards and $2.8 million in combined potential value (97% coverage of the top customers by potential value), with the Environmental Protection Agency Office of Research and Development providing supplementary licensing work (7 awards, $87 thousand). Of the 31 total awards in the source, only 2 awards with combined potential value of $816 thousand face ultimate completion within the next twenty-four months, indicating limited near-term recompete exposure. Certara operates as a sub-recipient on three federal grants, including collaborations with Northeastern University (prime grantee) on FDA grant work focused on in vitro-in vivo correlations and bioequivalence methodologies for rectal and vaginal drug products (awards dated October 7, 2025 and May 5, 2025) and with the University of Texas at Austin on PBPK-based mechanistic in vitro-in vivo correlation development for PLGA implants (award dated March 3, 2025). The vendor's federal footprint reflects specialization in biopharmaceutical regulatory science modeling rather than broad IT or defense services.
Quick answers
Is Certara UK LIMITED registered in SAM.gov?
Yes. Certara UK LIMITED's SAM.gov registration is active through October 12, 2027.
How much has Certara UK LIMITED received in federal contracts?
Federal contracts obligated $162,802 to Certara UK LIMITED in fiscal year 2025 and $1,013,504 in fiscal years 2023 through 2027.
What is Certara UK LIMITED's most recent federal award?
Certara UK LIMITED's most recent federal contract award is BAA FY26C1CP53: advancing integration of in vitro topical product characterization and skin permeation data (75F40126C00071), from Food and Drug Administration, on September 30, 2026.
On GovTribe
See Certara UK LIMITED's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors